Notice of Intent: LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)
Posted
May 14, 2026
Due Date
Jun 4, 2026
Location
Bethesda, Maryland
Description
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=47ec968c84524dd3995719d89e75155a
Details
- Notice ID
- 47ec968c84524dd3995719d89e75155a
- NAICS Code
- 325412
- Classification Code
- 6505
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- SAFE-PLASMA Protocol
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- Filgrastim Biosimilar (VA-27-00012533)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NAC PHARMACEUTICALS (36E797)
- Nutrition Care Services; Military Treatment Facilities - Forts Irwin, Leonard Wood, Riley, Stewart, and West Point
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.242-NETWORK CONTRACT OFFICE 02 (36C242)
- Epinephrine Injector
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
- Notice of Intent to Sole Source the Co-sponsorship of a Forum on Traumatic Brain Injury with the National Academies of Science, Engineering, and Medicine (NASEM)
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- PANDHA-26-P-0000 046239 Security Support Services
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY